The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiinstitutional cohort study of patient outcomes in Child-Pugh (CP) B liver function treated with atezolizumab plus bevacizumab (A+B) for hepatocellular carcinoma (HCC).
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; Elevar Therapeutics; Guardant Health; Taiho Oncology
Speakers' Bureau - AstraZeneca; Taiho Oncology
Research Funding - Taiho Pharmaceutical
 
Tyler J. Zemla
No Relationships to Disclose
 
Kanchi Patell
No Relationships to Disclose
 
Nikolas Naleid
No Relationships to Disclose
 
Jennifer Gile
No Relationships to Disclose
 
Zhaohui Jin
No Relationships to Disclose
 
Nguyen H. Tran
Honoraria - Helsinn Therapeutics (Inst); QED Therapeutics (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); QED Therapeutics (Inst); TEMPUS (Inst)
Research Funding - Exact Sciences
 
Mitesh Borad
No Relationships to Disclose
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen
(OPTIONAL) Uncompensated Relationships - Binacea
 
Michael H. Storandt
No Relationships to Disclose